tirzepatide and chronic kidney disease improves outcomes in T2DM with increased CV risk Tirzepatide Prescribing Practices and Efficacy

No, it doesnt

The proposed mechanism centers on modulation of the nitric oxide system: BPC-157 counteracts L-NAME-induced eNOS blockade in rat models and supports vascular sprouting through VEGFR2 internalization (Hsieh et al., J Mol Med , 2017)

New research suggests GLP-1s may also help improve cholesterol levels, reduce heart disease risk, and even support kidney and liver health, Welch says

When extracellular NAD+ levels in the bloodstream rise above normal, as can happen with high-dose IV infusions, the body may interpret this as trauma within the body, leading to an immune response, and potentially causing inflammation

Reported effects include steadier focus and reduced stress-related cognitive fog, though rigorous Western trial confirmation is limited

Whether ongoing use is appropriate depends on individual circumstances and should be discussed with a prescriber